Publications

• Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.

  (Bliss LA, Strong EA, Gamblin TC.) J Surg Oncol. 2019 Apr;119(5):623-628.

• Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.

  (Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA.) Cancer Med. 2019 Mar;8(3):928-938.

• Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.

  (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC.) J Am Coll Surg. 2019 Mar;228(3):245-254.

• Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.

  (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN.) J Surg Res. 2019 Jan;233:154-162.

• Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

  (Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK.) JAMA Oncol. 2018 Nov 29.

• Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.

  (Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH.) J Surg Res. 2018 11;231:248-256.

• Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?

  (Johnson AC, Ethun CG, Liu Y, Lopez-Aguiar AG, Tran TB, Poultsides G, Grignol V, Howard JH, Bedi M, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Delman KA, Wood WC, Cardona K, Maithel SK.) J Am Coll Surg. 2018 Sep;227(3):357-366.e3.

• The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.

  (Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Weiss M, Bauer TW, Shen F, Poultsides GA, Marsh JW, IJzermans JNM, Koerkamp BG, Pawlik TM.) Surgery. 2018 09;164(3):411-418.

• Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence.

  (Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC.) J Surg Oncol. 2018 Jun;117(8):1664-1671.

• Ablation approach for primary liver tumors: Peri-operative outcomes.

  (Berger NG, Herren JL, Liu C, Burrow RH, Silva JP, Tsai S, Christians KK, Gamblin TC.) J Surg Oncol. 2018 Jun;117(7):1493-1499.

• The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network.

  (Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC.) Surgery. 2018 05;163(5):1028-1034.

• Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma.

  (Walden D, Kunnimalaiyaan S, Sokolowski K, Clark TG, Kunnimalaiyaan M.) Oncotarget. 2017 Oct 20;8(50):88069-88078.